🔎 Trials Near Me

Utama › Kanser Endometrium › Colorado › Aurora

Kajian klinikal Kanser Endometrium di Aurora, CO

14 kajian untuk Kanser Endometrium sedang mencari peserta di lokasi dalam dan sekitar Aurora (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

Mengambil pesertaFasa 2
  • UCHealth University of Colorado Hospital, Aurora
Semua umur · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05564377

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

Mengambil pesertaFasa 3
  • UCHealth University of Colorado Hospital, Aurora
Umur 18 ke atas · Wanita · Dikemas kini 2 Okt 2026 · NCT07198074

Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER

Mengambil pesertaFasa 2
  • UCHealth University of Colorado Hospital, Aurora
Umur 18 ke atas · Wanita · Dikemas kini 24 Sep 2026 · NCT05640999

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Mengambil pesertaFasa 1/2
  • University of Colorado Cancer Center, Aurora
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT06128551

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

Mengambil pesertaFasa 1
  • University of Colorado Cancer Center, Aurora
Umur 18 ke atas · Semua jantina · Dikemas kini 21 Sep 2026 · NCT05983432

A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors

Mengambil pesertaFasa 1/2
  • GSK Investigational Site, Aurora
Umur 18 ke atas · Semua jantina · Dikemas kini 16 Sep 2026 · NCT07213609

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

Mengambil pesertaKajian pemerhatian
  • University of Colorado, Aurora
Umur 18 ke atas · Semua jantina · Dikemas kini 14 Sep 2026 · NCT05059444

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

Mengambil pesertaFasa 1/2
  • Children's Hospital Colorado, Aurora
12 Months – 30 Years · Semua jantina · Dikemas kini 25 Ogo 2026 · NCT04851119

Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors

Mengambil pesertaFasa 1/2
  • Research Site, Aurora
Umur 18 hingga 130 · Semua jantina · Dikemas kini 21 Ogo 2026 · NCT05797168

A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma

Mengambil pesertaFasa 2
  • University of Colorado, Aurora
Umur 18 ke atas · Wanita · Dikemas kini 21 Ogo 2026 · NCT05548296

FOG-001 in Locally Advanced or Metastatic Solid Tumors

Mengambil pesertaFasa 1/2
  • University of Colorado, Aurora
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Ogo 2026 · NCT05919264

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

Mengambil pesertaFasa 1/2
  • University of Colorado Cancer Center, Aurora
Umur 18 ke atas · Semua jantina · Dikemas kini 7 Jul 2026 · NCT05768139

A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer

Mengambil pesertaFasa 1/2
  • University of Colorado Cancer Center, Aurora
Umur 18 ke atas · Semua jantina · Dikemas kini 4 Nov 2025 · NCT05902988

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Mengambil pesertaKajian pemerhatian
  • Massive Bio SYNERGY-AI site, Aurora
Semua umur · Semua jantina · Dikemas kini 28 Okt 2025 · NCT03452774

Kajian Kanser Endometrium di bandar lain

Kajian lain di Aurora

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.